vimarsana.com

Page 93 - ஆரோக்கியம் பராமரிப்பு ஆம்ப் மருத்துவமனைகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Nemysis Ltd Strengthens Its Scientific Advisory Board With Nutritional and Pharmaceutical Solutions Expert, Linda Cavaletti

Nemysis Ltd Strengthens Its Scientific Advisory Board With Nutritional and Pharmaceutical Solutions Expert, Linda Cavaletti Nemysis Ltd today announces the appointment of internationally recognized drug discovery and development expert Linda Cavaletti to its Scientific Advisory Board (SAB) News provided by Share this article Share this article DUBLIN, April 23, 2021 /PRNewswire/  Nemysis Ltd today announces the appointment of internationally recognized drug discovery and development expert Linda Cavaletti to its Scientific Advisory Board (SAB). Since its inception, Nemysis has initiated and developed high-value innovative R&D programs, including one targeting Celiac Disease and Non-Celiac Gluten intolerance, with the aim of bringing novel treatments to patients suffering from these conditions.

Executive Care Set to Open First New York City Office

Executive Care Set to Open First New York City Office Home health care company serves seniors, disabled and recovering individuals News provided by Share this article Share this article BROOKLYN, N.Y., April 23, 2021 /PRNewswire/ As family members age, their health, safety, and overall wellness are the top priorities for loved ones. Throughout the pandemic, home care has become an alternative solution that outranks the risks of isolation and crowding when moving elders into assisted living or nursing homes. Families across the country have been looking for alternative solutions. Executive Care is one of the leading home health care agencies in the country, and with rising demand, the firm is pleased to open its first office in Brooklyn, NY.

Global H1N1 Vaccines Markets Report 2021: Market Reached a Value of $1 8 Billion in 2020

Share this article Share this article ResearchAndMarkets.com s offering. The global H1N1 vaccines market reached a value of US$ 1.8 Billion in 2020. Looking forward, the global H1N1 vaccines market to exhibit moderate growth during the next five years. The H1N1 virus is an infectious disease characterized by a persistent cough, high fever, red-watery eyes, body aches and headache. The illness is known to have a detrimental effect on the existing chronic ailments, such as Pneumonia, Chronic Obstructive Pulmonary Disease (COPD) and Bronchitis, and can be fatal in severe cases. H1N1 vaccines are a preventive measure administered through intradermal and intranasal procedures to provide active immunization against the virus.

Keto-Friendly Support for the Liver and Kidneys

Share this article Share this article FORT LAUDERDALE, Fla., April 22, 2021 /PRNewswire/  Health and Wellness brand Suraksha Naturals has created two products distinctly tailored to supporting liver and kidney health. Both items fall under the company s Ketoveyda label, a product line devoted to supplementing the gaps created by the popular keto diet. The trending keto diet is a powerfully effective way to lose weight and regain a sense of health. However, a commitment to keto also has its shortcomings, including several nutritional gaps. Ketoveyda products aim to address these concerns by supplementing the diet with critical missing nutrients. For instance, studies have shown that eating keto can lead to elevated liver enzymes as well as additional stress on kidneys. Suraksha Naturals has answered these concerns with two products, Ketoveyda Herbal Liver Care Supplement and its Ketoveyda Herbal Kidney Care Supplement, respectively.

Pager® Achieves Key Security Milestones with Successful SOC 2 Type 2 Examination, HITRUST Certification for Google Cloud and Amazon Web Services

Pager® Achieves Key Security Milestones with Successful SOC 2 Type 2 Examination, HITRUST Certification for Google Cloud and Amazon Web Services News provided by Share this article Share this article NEW YORK, April 22, 2021 /PRNewswire/  Pager today announced that it has successfully completed the System and Organization Controls (SOC) 2 Type 2 examination and also achieved HITRUST certification on its Google Cloud environment. By reaching these key milestones, Pager reaffirms its commitment to strict data privacy and security and builds upon its existing frameworks and certifications. Pager s successful SOC 2 Type 2 examination demonstrates that it maintains the appropriate controls surrounding information systems and data security, availability, confidentiality, processing integrity, and privacy. 

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.